Pivotal Phase III SUNMO study demonstrated an 11.5 month median progression-free survival – three times longer than R-GemOx – ...

A single infusion of zimislecel, an investigational stem cell-based therapy, restored physiologic islet function and ...

A long-term study published in the June 2025 issue of Journal of Clinical Oncology; researchers conducted a retrospective ...

The full results of the phase III registrational SUNRISE trial were presented at the European Academy of Neurology 2025 Annual Congress, where eptinezumab ...

Moleculin Biotech gets US FDA positive feedback on paediatric study plan for Annamycin in children with R/R AML: Houston Saturday, June 21, 2025, 15:00 Hrs [IST] Moleculin Biotech ...

Exclusive Youtube Nerf videos from MacDannyGun! If you like this video click like and share it with others so we make more of ...

Speaking exclusively to Newsweek, parents Edna and Tony shared they will 'gladly' explain to their seven-month-old son the ...

High-profile backers had warned any strike on Iran would run counter to the anti-interventionism he'd promised to deliver.

The problem of poor patient adherence has been extensively researched, but the rates of nonadherence have not changed much in the past 3 decades. Healthcare providers play a unique and important ...

Results from the study continue to demonstrate the transformative potential of zimislecel with consistent and durable patient benefit – ...

Explore the science of creatine's effects on muscle growth and recovery. Discover how this go-to supplement can enhance your ...